• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.16% Nasdaq Down 0.08%

    Regeneron Pharmaceuticals, Inc. (REGN)

    -NasdaqGS
    511.08 Up 4.57(0.90%) Jul 2, 4:00PM EDT
    Add to Portfolio
    Prev Close:506.51
    Open:509.50
    Bid:496.51 x 100
    Ask:513.00 x 100
    1y Target Est:511.71
    Beta:0.71
    Earnings Date:Aug 3 - Aug 7 (Est.)
    Day's Range:505.29 - 512.50
    52wk Range:295.76 - 544.00
    Volume:374,932
    Avg Vol (3m):752,298
    Market Cap:53.79B
    P/E (ttm):163.97
    EPS (ttm):3.12
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for REGN

    Comparison

    Symbol% ChgMkt Cap
    REGNUp 0.90%53.79B
    AMGNDown 1.12%116.53B
    NVSUp 1.30%241.55B
    RHHBYUp 0.09%N/A

    Key Statistics

    Forward P/E (1 yr):38.00
    P/S (ttm):16.90
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :11.17
    Quarterly EPS Est (Jun-15) :2.78
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):2.28

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Regeneron Pharmaceuticals, Inc., a biopharmaceutical company, discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions worldwide. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback